TummyTrimmer.net

It would seem which there might be at least three very good reasons to invest within the little pharmaceutical biotech business such as Amarin Corp.(AMRN), even during this recessionary period. The significance as well as value of the product would be the major attraction. The health as well as positioning of the company itself would be the 2nd important factor, as well as of the course, timing cannot be underestimated

Amarin Corp. is a Dublin-based business that runs its scientific research out of Mystic, Connecticut. Not 1 of the megoliths in the industry, the company’s stock could be picked up for less than $1 not too long ago, and no real income has been generated within the last Three years. In fact, 2009 saw the net loss of $59 million. Utilizing the potentially amazing results of the 1st of 2 final-phase trials of its brand new drug, AMR101, its status may be around to change. Within fact, stock value has already doubled this particular year and recently risen 65% to $5.85 because of 11/29.

The still-unsettled issue of healthcare reform may have some investors wondering if the pharmaceutical industry is a good choice right now. In fact, when another 30 million Americans are added to the health insurance lists, sales of drugs such as AMR101 will probably increase. With a co-pay in place, more patients will be willing to accept drug treatments that might have been financially prohibitive before. Certainly there is no imminent danger of the majority of Americans suddenly giving up fast foods and our unhealthy eating habits. Considering all things, this may be an excellent time to invest in a drug that can counteract the effects of too many indulgent lifestyles. Bring on the Christmas turkey!

The latest omega 3 drug looks like a very exciting opportunity. Fish oil has been used for many years in Japan, and is used to treat nervous system disorders. The safety record is also great. This record is key to getting the highly touted FDA approval. It is widely known on the street that if the FDA does not approve, time to sell the stock. If they approve, and you bought the stock, you could be sitting on a goldmine. The benefits of AMR101 include: 1) no fishy burps 2) does not increase LDL 3) and reduces Triglycerides in almost half.

The market for AMR101 could be much larger than Lavaza as it looks like it is effective in even patients with Triglycerides levels which are only moderately high. Out of 330 million Americans, only 3.8 million have levels of Tris that are high. However, 40 million other Americans have moderate levels. These moderate levels are sometime associated with heart disease. Putting all of the potential markets for this drug, they could be looking at a market of over 100 million customers in just the United States. Quite amazing.

If you want to learn more about this subject or about how to buy stocks online, then visit Alexander Forsythe’s site on how to learn day trading and get the education you need.